Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 70

1.

High-resolution immunophenotyping of subcellular compartments in tissue microarrays by enzyme metallography.

Tubbs R, Pettay J, Powell R, Hicks DG, Roche P, Powell W, Grogan T, Hainfeld JF.

Appl Immunohistochem Mol Morphol. 2005 Dec;13(4):371-5.

PMID:
16280669
[PubMed - indexed for MEDLINE]
2.

Analytical validation and interobserver reproducibility of EnzMet GenePro: a second-generation bright-field metallography assay for concomitant detection of HER2 gene status and protein expression in invasive carcinoma of the breast.

Downs-Kelly E, Pettay J, Hicks D, Skacel M, Yoder B, Rybicki L, Myles J, Sreenan J, Roche P, Powell R, Hainfeld J, Grogan T, Tubbs R.

Am J Surg Pathol. 2005 Nov;29(11):1505-11.

PMID:
16224218
[PubMed - indexed for MEDLINE]
3.

Bright-field in situ hybridization for HER2 gene amplification in breast cancer using tissue microarrays: correlation between chromogenic (CISH) and automated silver-enhanced (SISH) methods with patient outcome.

Francis GD, Jones MA, Beadle GF, Stein SR.

Diagn Mol Pathol. 2009 Jun;18(2):88-95. doi: 10.1097/PDM.0b013e31816f6374.

PMID:
19430296
[PubMed - indexed for MEDLINE]
4.

The specificity of interphase FISH translocation probes in formalin fixed paraffin embedded tissue sections is readily assessed using automated staining and scoring of tissue microarrays constructed from murine xenografts.

Tubbs RR, Pettay J, Barry TS, Swain E, Loftus M, Cook JR, Skacel M, Paine G, Roche P, Grogan T.

J Mol Histol. 2007 May;38(2):159-65. Epub 2006 Nov 9.

PMID:
17094016
[PubMed - indexed for MEDLINE]
5.

Metallographic in situ hybridization.

Powell RD, Pettay JD, Powell WC, Roche PC, Grogan TM, Hainfeld JF, Tubbs RR.

Hum Pathol. 2007 Aug;38(8):1145-59. Review.

PMID:
17640553
[PubMed - indexed for MEDLINE]
6.

In situ aromatase expression in primary tumor is associated with estrogen receptor expression but is not predictive of response to endocrine therapy in advanced breast cancer.

Lykkesfeldt AE, Henriksen KL, Rasmussen BB, Sasano H, Evans DB, Møller S, Ejlertsen B, Mouridsen HT.

BMC Cancer. 2009 Jun 16;9:185. doi: 10.1186/1471-2407-9-185.

PMID:
19531212
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Construction and validation of tissue microarrays of ductal carcinoma in situ and terminal duct lobular units associated with invasive breast carcinoma.

Yang XR, Charette LA, Garcia-Closas M, Lissowska J, Paal E, Sidawy M, Hewitt SM, Rimm DL, Sherman ME.

Diagn Mol Pathol. 2006 Sep;15(3):157-61.

PMID:
16932071
[PubMed - indexed for MEDLINE]
8.

Tissue microarrays for routine diagnostic assessment of HER2 status in breast carcinoma.

Drev P, Grazio SF, Bracko M.

Appl Immunohistochem Mol Morphol. 2008 Mar;16(2):179-84. doi: 10.1097/PAI.0b013e31806875e1.

PMID:
18227723
[PubMed - indexed for MEDLINE]
9.

Analysis of ERBB2 and TOP2A gene status using fluorescence in situ hybridization versus immunohistochemistry in localized breast cancer.

Bouchalová K, Trojanec R, Kolár Z, Cwiertka K, Cernáková I, Mihál V, Hajdúch M.

Neoplasma. 2006;53(5):393-401.

PMID:
17013533
[PubMed - indexed for MEDLINE]
10.

Automated subcellular localization and quantification of protein expression in tissue microarrays.

Camp RL, Chung GG, Rimm DL.

Nat Med. 2002 Nov;8(11):1323-7. Epub 2002 Oct 21.

PMID:
12389040
[PubMed - indexed for MEDLINE]
11.

Evaluation of automated silver-enhanced in situ hybridization (SISH) for detection of HER2 gene amplification in breast carcinoma excision and core biopsy specimens.

Shousha S, Peston D, Amo-Takyi B, Morgan M, Jasani B.

Histopathology. 2009 Jan;54(2):248-53. doi: 10.1111/j.1365-2559.2008.03185.x.

PMID:
19207950
[PubMed - indexed for MEDLINE]
12.

[Analysis of HER2 gene status in breast cancer with HER2 protein overexpression].

Zeng X, Liang ZY, Wu SF, Zhou WX, Gao J, Liu TH.

Zhonghua Bing Li Xue Za Zhi. 2006 Oct;35(10):584-8. Chinese.

PMID:
17134563
[PubMed - indexed for MEDLINE]
13.

c-erbB-2 (HER-2/neu) immunohistochemistry in invasive breast cancer: is there concordance between standard sections and tissue microarrays?

Selvarajan S, Tan SY, Sii LH, Tan PH.

Pathology. 2006 Aug;38(4):316-20.

PMID:
16916720
[PubMed - indexed for MEDLINE]
14.

Tissue microarrays compared with whole sections and biochemical analyses. A subgroup analysis of DBCG 82 b&c.

Kyndi M, Sørensen FB, Knudsen H, Overgaard M, Nielsen HM, Andersen J, Overgaard J.

Acta Oncol. 2008;47(4):591-9. doi: 10.1080/02841860701851871.

PMID:
18465327
[PubMed - indexed for MEDLINE]
15.

B-cell non-Hodgkin lymphomas in Uganda: an immunohistochemical appraisal on tissue microarray.

Tumwine LK, Campidelli C, Righi S, Neda S, Byarugaba W, Pileri SA.

Hum Pathol. 2008 Jun;39(6):817-23. doi: 10.1016/j.humpath.2007.10.025. Epub 2008 Apr 23.

PMID:
18436278
[PubMed - indexed for MEDLINE]
16.

Differential tissue and subcellular expressionof ERM proteins in normal and malignant tissues: cytoplasmic ezrin expression has prognostic signficance for head and neck squamous cell carcinoma.

Madan R, Brandwein-Gensler M, Schlecht NF, Elias K, Gorbovitsky E, Belbin TJ, Mahmood R, Breining D, Qian H, Childs G, Locker J, Smith R, Haigentz M Jr, Gunn-Moore F, Prystowsky MB.

Head Neck. 2006 Nov;28(11):1018-27.

PMID:
16783828
[PubMed - indexed for MEDLINE]
17.

A new rabbit monoclonal antibody (4B5) for the immunohistochemical (IHC) determination of the HER2 status in breast cancer: comparison with CB11, fluorescence in situ hybridization (FISH), and interlaboratory reproducibility.

Powell WC, Hicks DG, Prescott N, Tarr SM, Laniauskas S, Williams T, Short S, Pettay J, Nagle RB, Dabbs DJ, Scott KM, Brown RW, Grogan T, Roche PC, Tubbs RR.

Appl Immunohistochem Mol Morphol. 2007 Mar;15(1):94-102.

PMID:
17536315
[PubMed - indexed for MEDLINE]
18.

Quality aspects of the tissue microarray technique in a population-based cohort with ductal carcinoma in situ of the breast.

Wärnberg F, Amini RM, Goldman M, Jirström K.

Histopathology. 2008 Dec;53(6):642-9. doi: 10.1111/j.1365-2559.2008.03156.x.

PMID:
19076680
[PubMed - indexed for MEDLINE]
19.

[Comparision of HER2/neu oncogene detected by chromogenic in-situ hybridization and immunohistochemistry in breast cancer].

Zhang GH, Shi DR, Liang XM, Hou JH, Kang SY, Zhu WD, Li XB, Shao Y, Chen LR, Zhou Y.

Zhonghua Bing Li Xue Za Zhi. 2006 Oct;35(10):580-3. Chinese.

PMID:
17134562
[PubMed - indexed for MEDLINE]
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk